secwatch / observer
8-K filed November 3, 2023, 7:59 PM ET ticker ACH CIK 0000075252
earnings confidence high sentiment neutral materiality 0.65

Owens & Minor Q3 revenue up 3.8% to $2.59B; adjusted EPS $0.44, debt cut $188M

ACCENDRA HEALTH INC/VA/

2023-Q3 EPS reported -$0.78 revenue$7,677,817,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

ACCENDRA HEALTH INC/VA/ reported nine months ended September 30, 2023 results: revenue $7,678.

Period
nine months ended September 30, 2023
Revenue
$7,678
Result
reported results
Exact text from the filing
YTD YTD ($ in millions, except per share data) 3Q23 3Q22 2023 2022 Revenue $2,592 $2,497 $7,678 $7,404 Operating income, GAAP $23.8 $60.2 $44.5 $196.4
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ACCENDRA HEALTH INC/VA/ reported third quarter ended September 30, 2023 results: revenue $2.59 billion, net income Net loss per common share of $(0.08), EPS $(0.08).

Period
third quarter ended September 30, 2023
Revenue
$2.59 billion
Net income
Net loss per common share of $(0.08)
EPS
$(0.08)
Result
reported results
Exact text from the filing
2023 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2023. Third Quarter Key Highlights: • Consolidated revenue of $2.59 billion • Net loss per common share of $(0.08) and adjusted net income per common share of $0.44 • $188 million in total debt pay down and $117 million reduction in net debt “Our
View on SEC.gov

Browse all earnings releases →

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR
accession 0000075252-23-000050
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.